Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery
Launched by MCGILL UNIVERSITY HEALTH CENTRE/RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE · Jun 14, 2006
Trial Information
Current as of May 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • status post cardiac surgery
- • pulmonary artery occlusion catheter in place
- • informed consent
- • morning case (must be out of OR by 2:00 PM
- Exclusion Criteria:
- • excessive bleeding (\> 200 cc/hr)
- • intraaortic balloon pump
- • refusal by treating team
- • emergency cases
- • patients with known adverse reactions to starch solutions
About Mcgill University Health Centre/Research Institute Of The Mcgill University Health Centre
The McGill University Health Centre (MUHC) and the Research Institute of the McGill University Health Centre (RI-MUHC) are leading institutions in clinical research and healthcare innovation. With a commitment to advancing medical knowledge and improving patient outcomes, the MUHC integrates cutting-edge research with high-quality patient care. The RI-MUHC fosters a collaborative environment where multidisciplinary teams engage in transformative research across various fields, including oncology, neurology, and cardiovascular health. By leveraging state-of-the-art facilities and a robust network of clinical expertise, both entities strive to translate scientific discoveries into effective treatments, ultimately enhancing the quality of life for patients locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Patients applied
Trial Officials
sheldon magder, md
Principal Investigator
McGill University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials